IGC Pharma Reports Second Quarter Fiscal 2024 Results - IGC Pharma, INC.

Press

Releases

November 13, 2023

IGC Pharma Reports Second Quarter Fiscal 2024 Results

Related Posts

IGC Pharma Announces Participation in BioPartnering @ JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025

December 20, 2024

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer’s Therapy Addressing Cognitive Impairment and Underlying Disease Pathology

December 2, 2024

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer’s Treatment

November 25, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024